GlassScriptPhysician profile
Christopher R Lemons
NPI 1023657236
$6,138.53
in general payments reported to CMS, 2019-2025
47 companies · $1,862 in 2025
The $1,862 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $795 · 2022: $1,448 · 2023: $415 · 2024: $1,619 · 2025: $1,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,895.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $775.21 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $617.74 | 2021-2025 | Otezla, Repatha, Evenity |
| Abbvie INC. | $464.32 | 2021-2025 | |
| Lilly USA, LLC | $463.63 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Novo Nordisk INC | $340.97 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $322.84 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $313.45 | 2021-2025 | |
| Astellas Pharma US INC | $289.26 | 2021-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $264.03 | 2021-2025 | Xifaxan, Trulance |
| Lundbeck LLC | $175.86 | 2022-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $164.30 | 2024-2025 | Fanapt, Hetlioz |
| Amarin Pharma, INC. | $129.36 | 2021-2022 | |
| Abbott Laboratories | $123.30 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $122.08 | 2021-2023 | Steglatro, Belsomra, Steglujan |
| Otsuka America Pharmaceutical, INC. | $109.39 | 2022-2025 | Rexulti |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lemons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.